AN2 Therapeutics
ANTX
ANTX
37 hedge funds and large institutions have $9.88M invested in AN2 Therapeutics in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $10.5M → $9.88M (-$633K)
Holders
37
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$170K | |
| 2 | +$112K | |
| 3 | +$108K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$74.5K |
| 5 |
AC
Almitas Capital
Santa Monica,
California
|
+$59.3K |
Top Sellers
| 1 | -$54.9K | |
| 2 | -$52.3K | |
| 3 | -$28.9K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$23.5K |
| 5 |
AA
ACT Advisors
Asheville,
North Carolina
|
-$16.8K |
